Trillium Therapeutics TRIL Stock
$19.86
0.368873%
Add to favorites
COUNTRY
Exchange
Market Cap
$0.00
LOW - HIGH [24H]
$19.83
-
$19.90
VOLUME [24H]
$565.00
P/E Ratio
0
Earnings per share
$0.00
Trillium Therapeutics Price Chart
Trillium Therapeutics TRIL Financial and Trading Overview
| Trillium Therapeutics stock price | 19.86 USD |
| Previous Close | 19.79 USD |
| Open | 19.83 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 19.83 - 19.9 USD |
| 52 Week Range | 19.23 - 21.27 USD |
| Volume | 565 USD |
| Avg. Volume | 1.65K USD |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
TRIL Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Trillium Therapeutics Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 21.27 USD |
| 52 Week Low | 19.23 USD |
| 50-Day Moving Average | 20.14 USD |
| 200-Day Moving Average | 20.13 USD |
TRIL Share Statistics
| Avg. Volume (3 month) | 1.65K USD |
| Avg. Daily Volume (10-Days) | 621 USD |
| Shares Outstanding | N/A |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | N/A |
| Operating Margin (ttm) | N/A |
| Gross Margin | N/A |
| EBITDA Margin | N/A |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Trillium Therapeutics
| Country | United States |
| State | N/A |
| City | N/A |
| Address | N/A |
| ZIP | N/A |
| Phone | N/A |
| Website | N/A |
| Industry | |
| Sector(s) | |
| Full Time Employees | N/A |
Under normal circumstances, the fund will invest at least 80% of its net assets, plus borrowings for investment purposes, in equity securities of Trillion Companies and/or financial instruments (such as swaps) that provide indirect exposure to Trillion Companies. The index tracks the performance of U.S. exchange-listed companies with market capitalizations of $1 trillion or greater (“Trillion Companies”). The fund is non-diversified.
Q&A For Trillium Therapeutics Stock
What is a current TRIL stock price?
Trillium Therapeutics TRIL stock price today per share is 19.86 USD.
How to purchase Trillium Therapeutics stock?
You can buy TRIL shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Trillium Therapeutics?
The stock symbol or ticker of Trillium Therapeutics is TRIL.
How many shares does Trillium Therapeutics have in circulation?
The max supply of Trillium Therapeutics shares is 0.
What is Trillium Therapeutics Price to Earnings Ratio (PE Ratio)?
Trillium Therapeutics PE Ratio is now.
What was Trillium Therapeutics earnings per share over the trailing 12 months (TTM)?
Trillium Therapeutics EPS is 0 USD over the trailing 12 months.
Trillium Therapeutics TRIL included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite Total Return XCMP | 31702.11 USD — |
-4.17
|
— — | 31626.94 USD — | 32765.94 USD — | — - | — — |
| US Tech Capital Market Composite RCMP | 141.63 USD — |
-6.08
|
— — | 140.4 USD — | 147.91 USD — | — - | — — |
- {{ link.label }} {{link}}